Dr David. C Briggs PhD CSci MRSB is a structural biologist with 20 years' experience working in academic and non-profit institutes around the UK. He is currently a senior laboratory research scientist at the Francis Crick Institute in London, where he works in the Signaling and Structural Biology lab on understanding (and where possible treating) various cancers and neurodegenerative disorders.
If Alphafold2 is as transformative as its makers claim, keeping its knowledge secret is troubling - especially when medical advances could be made if this technology is as good as they claim.
